Skip to main content

Nuvectis Pharma, Inc.

NVCT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001875558

In the last 90 days, Nuvectis Pharma, Inc. insiders filed 2 open-market purchases and 0 sales; 82 institutions reported holding it in 13F filings for Q2 2026, worth $189.0M in total; no superinvestor holds it.

Members of Congress who traded NVCT

No member of Congress has reported a trade in Nuvectis Pharma, Inc. since 2020.

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.